• 

  The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation 

  Charman, Tony; Loth, Eva; Tillmann, Julian; Crawley, Daisy; Wooldridge, Caroline; Goyard, David; Ahmad, JumanaAuyeung, BonnieAmbrosino, SaraBanaschewski, TobiasBaron-Cohen, SimonBaumeister, SarahBeckmann, ChristianBölte, SvenBourgeron, ThomasBours, CarstenBrammer, MichaelBrandeis, DanielBrogna, Claudiade Bruijn, YvetteChakrabarti, BhismadevCornelissen, InekeAcqua, Flavio DDumas, GuillaumeDurston, SarahEcker, ChristineFaulkner, JessicaFrouin, VincentGarcés, PilarHam, LindsayHayward, HannahHipp, JoergHolt, Rosemary JIsaksson, JohanJohnson, Mark HJones, Emily J HKundu, PrantikLai, Meng-ChuanD’ardhuy, Xavier LLombardo, Michael VLythgoe, David JMandl, RenéMason, LukeMeyer-Lindenberg, AndreasMoessnang, CarolinMueller, NicoO’Dwyer, LaurenceOldehinkel, MarianneOranje, BobPandina, GahanPersico, Antonio MRuggeri, BarbaraRuigrok, Amber N VSabet, JessicaSacco, RobertoCáceres, Antonia S JSimonoff, EmilyToro, RobertoTost, HeikeWaldman, JackWilliams, Steve C RZwiers, Marcel PSpooren, WillMurphy, Declan G MBuitelaar, Jan K et al. (2017-06-23)

  Abstract Background The EU-AIMS Longitudinal European Autism Project (LEAP) is to date the largest multi-centre, multi-disciplinary observational study on biomarkers for autism ...
• 

  The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders 

  Loth, Eva; Charman, Tony; Mason, Luke; Tillmann, Julian; Jones, Emily J H; Wooldridge, Caroline; Ahmad, JumanaAuyeung, BonnieBrogna, ClaudiaAmbrosino, SaraBanaschewski, TobiasBaron-Cohen, SimonBaumeister, SarahBeckmann, ChristianBrammer, MichaelBrandeis, DanielBölte, SvenBourgeron, ThomasBours, Carstende Bruijn, YvetteChakrabarti, BhismadevCrawley, DaisyCornelissen, InekeAcqua, Flavio DDumas, GuillaumeDurston, SarahEcker, ChristineFaulkner, JessicaFrouin, VincentGarces, PilarGoyard, DavidHayward, HannahHam, Lindsay MHipp, JoergHolt, Rosemary JJohnson, Mark HIsaksson, JohanKundu, PrantikLai, Meng-ChuanD’ardhuy, Xavier LLombardo, Michael VLythgoe, David JMandl, RenéMeyer-Lindenberg, AndreasMoessnang, CarolinMueller, NicoO’Dwyer, LaurenceOldehinkel, MarianneOranje, BobPandina, GahanPersico, Antonio MRuigrok, Amber N VRuggeri, BarbaraSabet, JessicaSacco, RobertoCáceres, Antonia S JSimonoff, EmilyToro, RobertoTost, HeikeWaldman, JackWilliams, Steve C RZwiers, Marcel PSpooren, WillMurphy, Declan G MBuitelaar, Jan K et al. (2017-06-23)

  Abstract Background The tremendous clinical and aetiological diversity among individuals with autism spectrum disorder (ASD) has been a major obstacle to the development of ...
• 

  Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe 

  Lu, Mengfei; Lewis, Cathryn M; Traylor, Matthew (2017-06-19)

  Abstract Background Rapid advances in scientific research have led to an increase in public awareness of genetic testing and pharmacogenetics. Direct-to-consumer ...
• 

  Micro-drinking behaviours and consumption of wine in different wine glass sizes: a laboratory study 

  Zupan, Z.; Pechey, R.; Couturier, D. L; Hollands, G. J; Marteau, Theresa M. (2017-06-12)

  Abstract Background Tableware size may influence how much food and non-alcoholic drink is consumed. Preliminary evidence of the impact of glass size on purchasing of alcoholic ...

View more